162. Pemphigoid Clinical trials / Disease details

Clinical trials : 83 / Drugs : 128 - (DrugBank : 51) / Drug target genes : 33 - Drug target pathways : 142

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04128176 (ClinicalTrials.gov)	May 25, 2023	12/10/2019	Efficacy and Safety of Rituximab Combined With Omalizumab in Patients With Bullous Pemphigoid	An Open-Label Study to Evaluate the Efficacy and Safety of Rituximab Combined With Omalizumab in Patients With Bullous Pemphigoid	Bullous Pemphigoid	Drug: Rituximab combined with Omalizumab	University of California, Davis	NULL	Not yet recruiting	18 Years	90 Years	All	15	Phase 3	United States
2	NCT00472030 (ClinicalTrials.gov)	August 2007	8/5/2007	Efficacy and Safety of Omalizumab in Bullous Pemphigoid	An Open Label Case Series on the Effects of Xolair (Omalizumab) in Bullous Pemphigoid	Bullous Pemphigoid	Drug: Omalizumab;Drug: prednisone	University of Iowa	Genentech, Inc.	Completed	18 Years	N/A	All	2	Phase 4	United States